NREP
NEW REPRESENTATIVE AT IB RECEIVED
01/01/2026
Back to search
Official data from USPTO
2 BIND MOLECULAR INTERACTIONS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
01/02/2026
Trademark type
Combined
Nice classes
1, 42
Filing date
06/02/2021
Registration date
08/22/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/22/2023
Last transaction
01/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
27
Owner location
DE
Examiner
OJEYEMI,ASHLEY CHRISTINE
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the terms "2 BIND" in red having a strike through above the terms "MOLECULAR INTERACTIONS" in blue. The color white represents background, outlining, shading, and/or transparent area and is not part of the mark.".
Holders and representatives
Holders
2bind GmbH
Representatives
Elissa A. Tisdahl Weisberg I.P. Law, P.A.
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for scientificresearchlaboratory purposesother than for medical or veterinary purposes; chemicalbiochemical and biological preparations for use in biophysical and biotechnologicalscientificresearchlaboratoryindustrialcommercial process; diagnostic reagentsbuffersbuffer solutionsbuffer-screening stock solutionsbioliquidsligandstherapeutic antibodiesmonoclonal antibodiesantibody reagentsproteinsaptamersantigensbiochemicals for in vitro and in vivo applications for scientificresearchlaboratory purposesall the aforesaid except for medical and veterinary purposes; chemicalbiochemical and biological agentscompoundspreparationsreagents and substances for the developmentmanufacture and research of pharmaceutical preparationmedicinesmedicine productsmedical diagnosticsdiagnostic and analysis productsfoodcosmeticscleaning preparation and disinfectants in the fields of biologybiotechnologybiochemistrychemistrypharmacy and cosmeticsother than for medical or veterinary purposes; chemicalbiochemical and biological preparations for the developmentmanufacture and research of biophysical and biotechnological pharmaceutical preparationmedicinesmedical productsmedical diagnosticsdiagnostic and analysis productsfoodcosmeticscleaning preparationsdisinfectants
Class 42
Scientific servicesconducting of biophysical interaction analyses by means of microscale thermophoresis technology for determining binding parameters of molecular interactions; scientific laboratory servicesplasmid cloningprotein expression in E. coliprotein purification and fluorescent protein marking; scientific and technological servicesscientific researchanalysistesting in the field of biophysical analytics; research and development services in the fields of pharmacybiologymolecular biologygenetic sciencebiochemistrybiotechnologychemistryfood industry and cosmetics; medical and pharmaceutical research and development; scientifictechnological and industrial biochemical analysis and research; scientific laboratory services; scientific research laboratory services; analytical scientific laboratory services; conducting of scientific experiments and teststesting of pharmaceuticalscosmeticsfoodstuffmedical productsmedical diagnosticsdiagnosticanalysis products; consultancy in the field of scientificindustrial and technological research and development in the pharmaceuticalmedicinalcosmeticsfood stuffbiotechnology fields; conducting of technical scientific feasibility studies; development of industrial processesdevelopment of testing specifications and procedures in the field of biophysical analytics; development of new products; development of new technology for others in the field of biophysical analytics; services for the development of methods of testing in the fields of pharmaceuticals and vaccinescosmeticsfood stuffmedical productsmedical diagnosticsdiagnostic and analysis products; research and development services and industrialscientific and technological laboratory services in the field of protein and RNA-based medicine developmentantibody developmentprotein analysisaptamer development and the determination of molecular interactions
Publications
History of USPTO decisions and trademark events.
48 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/25/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/30/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/30/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/30/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/30/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/30/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/11/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/22/2023
FIMP
FINAL DISPOSITION PROCESSED
11/22/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/22/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/22/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
08/22/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/18/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/14/2023
GPNX
NOTIFICATION PROCESSED BY IB
06/06/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/06/2023
PUBO
PUBLISHED FOR OPPOSITION
06/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/17/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/17/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/17/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
04/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/22/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/22/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/22/2023
DOCK
ASSIGNED TO EXAMINER
03/06/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/06/2023
GNFR
FINAL REFUSAL E-MAILED
03/06/2023
CNFR
FINAL REFUSAL WRITTEN
03/06/2023
DOCK
ASSIGNED TO EXAMINER
02/21/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
12/07/2022
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/22/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/31/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/31/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/31/2022
DOCK
ASSIGNED TO EXAMINER
05/17/2022
RFNT
REFUSAL PROCESSED BY IB
04/11/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/21/2022
RFRR
REFUSAL PROCESSED BY MPU
03/21/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/18/2022
CNRT
NON-FINAL ACTION WRITTEN
02/17/2022
DOCK
ASSIGNED TO EXAMINER
02/17/2022
MAFR
APPLICATION FILING RECEIPT MAILED
01/18/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/14/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/13/2022
Continuous trademark protection
Get notified about every new filing that threatens 2 BIND MOLECULAR INTERACTIONS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.